Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India - Authors' reply
Lancet Infect Dis
.
2022 Apr;22(4):447.
doi: 10.1016/S1473-3099(22)00120-7.
Authors
Ramachandran Thiruvengadam
1
,
Amit Awasthi
1
,
Shinjini Bhatnagar
1
,
Pramod Kumar Garg
2
;
DBT Consortium for COVID-19 Research
Affiliations
1
Translational Health Science and Technology Institute, Faridabad 121001, India.
2
Translational Health Science and Technology Institute, Faridabad 121001, India. Electronic address: pgarg@thsti.res.in.
PMID:
35338864
PMCID:
PMC8942565
DOI:
10.1016/S1473-3099(22)00120-7
No abstract available
Publication types
Letter
Comment
MeSH terms
ChAdOx1 nCoV-19*
Humans
India / epidemiology
Substances
ChAdOx1 nCoV-19